EMD Serono

234 articles with EMD Serono

• Bioject Medical Technologies Inc. Announces New Supply Agreement with Merck Serono

  10/11/2007

• ZymoGenetics, Inc. (Jobs) and Merck Serono Receive FDA Special Protocol Assessment for Atacicept Pivotal Study in Lupus Nephritis

  10/4/2007

• Immunicon Corporation Announces Laboratory Services and Assay Development Agreements with Merck Serono

  8/29/2007

• Gene Logic Inc. Establishes Agreement with Merck Serono to Discover New Development Paths for Multiple Clinical-Stage Drug Candidates

  8/23/2007

• BioMarin Pharmaceutical Inc.'s (Jobs) Kuvan Receives Priority Review Status from FDA

  7/26/2007

• Squeeze Out of Merck Serono Shares Successfully Completed

  7/6/2007

• BioMarin Pharmaceutical Inc. Submits New Drug Application for U.S. Marketing Authorization of Kuvan for Phenylketonuria (PKU)

  5/24/2007

• Merck Serono to Voluntarily Delist and Deregister its Bearer Shares and American Depositary Shares (Evidenced by American Depositary Receipts)

  4/5/2007

• Merck Serono Preliminary Q4/FY 06 Results - March 1

  2/28/2007

• Aurigene Discovery Technologies Limited And Merck Serono Enter A Discovery Collaboration To Identify Therapeutics For Autoimmune Disorders

  2/2/2007

• The Day In Review: Alfacell Receives Orphan Drug Status For Onconase

  1/30/2007

• Merck Serono Launches easypod(R), First Electronic Growth Hormone Injection Device

  1/30/2007

• Merck Serono Has Initiated The ONWARD Study To Evaluate Oral Cladribine As Add-on Treatment For Multiple Sclerosis

  1/24/2007

• Merck Serono Completes Patient Enrollment In CLARITY Phase III Pivotal Clinical Trial Of Oral Cladribine

  1/16/2007